Gerresheimer AG (GXI.DE)
EUR 51.85
(-2.17%)
EUR 51.85
(-2.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.99 Billion EUR | 9.54% |
| 2022 | 1.81 Billion EUR | 21.3% |
| 2021 | 1.49 Billion EUR | 5.58% |
| 2020 | 1.41 Billion EUR | 1.91% |
| 2019 | 1.39 Billion EUR | 1.79% |
| 2018 | 1.36 Billion EUR | 1.44% |
| 2017 | 1.34 Billion EUR | -1.98% |
| 2016 | 1.37 Billion EUR | -0.13% |
| 2015 | 1.37 Billion EUR | 6.76% |
| 2014 | 1.29 Billion EUR | 1.9% |
| 2013 | 1.26 Billion EUR | 3.84% |
| 2012 | 1.21 Billion EUR | 11.36% |
| 2011 | 1.09 Billion EUR | 6.82% |
| 2010 | 1.02 Billion EUR | 2.46% |
| 2009 | 1 Billion EUR | -5.65% |
| 2008 | 1.06 Billion EUR | 10.69% |
| 2007 | 957.7 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 466.13 Million EUR | -14.5% |
| 2024 Q2 | 502.37 Million EUR | 7.77% |
| 2024 Q3 | 498.51 Million EUR | -0.77% |
| 2023 Q3 | 487.94 Million EUR | -2.33% |
| 2023 Q4 | 545.17 Million EUR | 11.73% |
| 2023 FY | 1.99 Billion EUR | 9.54% |
| 2023 Q1 | 457.77 Million EUR | -13.42% |
| 2023 Q2 | 499.6 Million EUR | 9.14% |
| 2022 Q3 | 472.97 Million EUR | 6.38% |
| 2022 Q4 | 528.7 Million EUR | 11.78% |
| 2022 FY | 1.81 Billion EUR | 21.3% |
| 2022 Q2 | 444.61 Million EUR | 19.91% |
| 2022 Q1 | 370.79 Million EUR | -14.98% |
| 2021 Q2 | 376.99 Million EUR | 24.49% |
| 2021 Q4 | 436.13 Million EUR | 14.16% |
| 2021 FY | 1.49 Billion EUR | 5.58% |
| 2021 Q1 | 302.84 Million EUR | -24.82% |
| 2021 Q3 | 382.03 Million EUR | 1.34% |
| 2020 Q1 | 303.86 Million EUR | -17.57% |
| 2020 FY | 1.41 Billion EUR | 1.91% |
| 2020 Q4 | 402.81 Million EUR | 15.36% |
| 2020 Q3 | 349.17 Million EUR | -3.79% |
| 2020 Q2 | 362.93 Million EUR | 19.44% |
| 2019 Q4 | 368.61 Million EUR | 2.8% |
| 2019 Q3 | 358.59 Million EUR | 0.58% |
| 2019 Q2 | 356.5 Million EUR | 15.55% |
| 2019 Q1 | 308.54 Million EUR | -21.11% |
| 2019 FY | 1.39 Billion EUR | 1.79% |
| 2018 Q1 | 290.36 Million EUR | -22.45% |
| 2018 FY | 1.36 Billion EUR | 1.44% |
| 2018 Q3 | 353.6 Million EUR | 6.3% |
| 2018 Q2 | 332.64 Million EUR | 14.56% |
| 2018 Q4 | 391.11 Million EUR | 10.61% |
| 2017 Q1 | 302.81 Million EUR | 4.58% |
| 2017 Q3 | 331.47 Million EUR | -2.37% |
| 2017 Q4 | 374.43 Million EUR | 12.96% |
| 2017 Q2 | 339.53 Million EUR | 12.13% |
| 2017 FY | 1.34 Billion EUR | -1.98% |
| 2016 Q3 | 373.05 Million EUR | 0.68% |
| 2016 Q2 | 370.53 Million EUR | 8.24% |
| 2016 Q4 | 289.53 Million EUR | -22.39% |
| 2016 FY | 1.37 Billion EUR | -0.13% |
| 2016 Q1 | 342.32 Million EUR | -8.71% |
| 2015 Q4 | 375 Million EUR | 9.01% |
| 2015 Q1 | 301.76 Million EUR | -9.43% |
| 2015 Q3 | 344.01 Million EUR | -3.49% |
| 2015 FY | 1.37 Billion EUR | 6.76% |
| 2015 Q2 | 356.44 Million EUR | 18.12% |
| 2014 Q1 | 297.48 Million EUR | -8.54% |
| 2014 FY | 1.29 Billion EUR | 1.9% |
| 2014 Q4 | 333.17 Million EUR | 2.85% |
| 2014 Q3 | 323.93 Million EUR | -3.43% |
| 2014 Q2 | 335.42 Million EUR | 12.75% |
| 2013 FY | 1.26 Billion EUR | 3.84% |
| 2013 Q1 | 296.69 Million EUR | -8.67% |
| 2013 Q2 | 327.07 Million EUR | 10.24% |
| 2013 Q4 | 325.24 Million EUR | 2.63% |
| 2013 Q3 | 316.91 Million EUR | -3.1% |
| 2012 Q4 | 324.85 Million EUR | 4.3% |
| 2012 Q1 | 268.8 Million EUR | -6.78% |
| 2012 FY | 1.21 Billion EUR | 11.36% |
| 2012 Q2 | 313.94 Million EUR | 16.79% |
| 2012 Q3 | 311.46 Million EUR | -0.79% |
| 2011 Q2 | 284.55 Million EUR | 20.26% |
| 2011 Q1 | 236.61 Million EUR | -12.95% |
| 2011 Q3 | 285.13 Million EUR | 0.21% |
| 2011 Q4 | 288.37 Million EUR | 1.14% |
| 2011 FY | 1.09 Billion EUR | 6.82% |
| 2010 Q3 | 259.35 Million EUR | -3.52% |
| 2010 Q1 | 224.82 Million EUR | -12.16% |
| 2010 Q4 | 271.82 Million EUR | 4.81% |
| 2010 Q2 | 268.8 Million EUR | 19.56% |
| 2010 FY | 1.02 Billion EUR | 2.46% |
| 2009 Q2 | 264.34 Million EUR | 11.37% |
| 2009 FY | 1 Billion EUR | -5.65% |
| 2009 Q1 | 237.34 Million EUR | 0.0% |
| 2009 Q3 | 242.57 Million EUR | -8.23% |
| 2009 Q4 | 255.95 Million EUR | 5.52% |
| 2008 FY | 1.06 Billion EUR | 10.69% |
| 2007 FY | 957.7 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 898.6 Million EUR | -121.509% |
| Carl Zeiss Meditec AG | 2.08 Billion EUR | 4.73% |
| Fielmann Aktiengesellschaft | 1.96 Billion EUR | -1.087% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 41.382% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 41.382% |